Some individuals may also experience an elevated heart rate or trouble sleeping [3]
During CVS, a small sample of the placenta is removed for testing
The intensity and type of side effects vary widely based on individual metabolism, starting dose, and gastrointestinal sensitivity
Journal of Metabolic Medicine, 12 (6), 512523
To view or add a comment, sign in Next-Generation GLP-1Based Therapies for Obesity: Comparative Weight Loss Outcomes Mean Percentage Weight Loss in Phase 3 Trials Orforglipron (oral GLP-1 receptor agonist) 6 mg: 7.5% 36 mg: 11.0% Placebo: 2.0% n 3,100
Retatrutide's triple-receptor action may offer enhanced fat loss compared to Mounjaro's dual-action mechanism, though both require resistance training and high protein intake to minimise muscle loss during cutting